XML 25 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 29, 2018
Dec. 30, 2017
Dec. 31, 2016
Operating activities:      
Net income $ 223,568 $ 163,317 $ 67,493
Adjustments to reconcile net income to cash provided by operating activities:      
Depreciation and amortization 44,061 50,880 52,633
Amortization of deferred financing costs and debt discount 8,539 6,112 6,116
Goodwill impairment 0 13,323 0
Impairment of intangible and long-lived assets 27 682 615
Write-off of net assets due to cessation of Spain operations 0 70 0
Share-based compensation expense 20,188 14,949 6,527
Deferred tax (benefit) provision (13,673) (48,216) 11,093
Allowance for doubtful accounts 130 (587) 363
Reserve for inventory obsolescence 7,906 7,823 5,109
Foreign currency exchange rate loss 2,036 202 1,270
Early extinguishment of debt, net 0 8,969 0
Changes in cash due to:      
Receivables (7,999) 5,444 (37)
Inventories (1,148) (4,504) (9,513)
Prepaid expenses (3,991) (4,359) (14,755)
Accounts payable 2,224 (14,507) 461
Accrued liabilities 16,600 4,414 (8,823)
Deferred revenue (17,198) 8,298 1,212
Other long term assets and liabilities, net (13,001) 5,683 1,512
Income taxes 27,323 4,281 (2,232)
Cash provided by operating activities 295,592 222,274 119,044
Investing activities:      
Capital expenditures (19,050) (13,732) (5,556)
Capitalized software expenditures (27,763) (26,916) (28,785)
Cash paid for acquisitions (7,100) 0 (2,898)
Other items, net (10,045) (143) (291)
Cash used for investing activities (63,958) (40,791) (37,530)
Financing activities:      
Net (payments) borrowings on revolver (25,000) 25,000 (48,000)
Proceeds from new long term debt 0 1,840,000 0
Financing costs and debt discount 0 (53,636) 0
Payments on long-term debt (57,750) (2,018,773) (165,323)
Taxes paid related to net share settlement of equity awards (25,020) (9,548) 0
Excess tax benefit of share-based compensation 0 0 973
Proceeds from stock options exercised 33,417 5,475 139
Payment of dividends 0 0 (11)
Cash used for financing activities (74,353) (211,482) (212,222)
Effect of exchange rate changes on cash and cash equivalents (3,361) 4,397 (2,162)
Net increase (decrease) in cash and cash equivalents 153,920 (25,602) (132,870)
Cash and cash equivalents, beginning of fiscal year 83,054 108,656 241,526
Cash and cash equivalents, end of fiscal year $ 236,974 $ 83,054 $ 108,656